This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

With Access To The Full, Customized TalkChart Solution, Physicians Can Experience The Real Power Of Personalized EHR

SALT LAKE CITY, June 30, 2013 /PRNewswire/ -- EvolveMed, an industry leader in medical technology designed to banish medical practice inefficiencies, is pleased to announce its new risk-free trial of TalkChart will be live for the entire month of July. But EvolveMed is offering physicians something beyond a standard, limited software trial. Instead, physicians will have access to a personalized experience that mirrors the unique electronic documentation software or dictation and transcription needs and workflow of each individual user, helping dramatically boost their medical charting efficiencies.

"Our biggest supporters and most vocal advocates of the tremendous benefits that TalkChart brings to medical practices have always been our users," said Andrea Jaques, Business Development Manager. "That's why we're excited to not just offer the chance for physicians to demo the software, but to really experience the full-featured, customized solution. Only a hands-on opportunity can demonstrate how innovative integrated platform will really improve their charting efficiency and workflow, and maximize the cost efficiency of their practice right out of the gate."

When physicians opt into the no-risk TalkChart trial, EvolveMed will work with them to integrate it directly into their existing EHR, and then fully customize and personalize their TalkChart implementation with complaint-specific content and custom web-based templates, shortcuts and more.

"We've designed the trial to make it easy as 1, 2, 3 to start working with the full TalkChart platform," said Jaques. "Sign up to start your subscription, customize your workflow (we'll help), and then start charting. When you take advantage of our risk-free trial, you'll have 90 days to explore and experience the effectiveness of TalkChart—satisfaction guaranteed, or we'll refund your subscription." This trial offer will be available throughout the month of July, ending 11:59 p.m. on July 31.

TalkChart was designed with the pain points of overworked, over-administrated physicians in mind. "Imagine not having to turn away patients, or schedule them months down the road," said Jaques. "Not wasting billable hours on administrative work, and growing practice revenues. A more efficient EMR, a more streamlined dictation and transcription service, and more accurate and actionable medical records can change your practice--and get you out the door on time every night."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 -1.15%
FB $117.58 0.73%
GOOG $693.01 0.29%
TSLA $240.76 -2.81%
YHOO $36.60 0.03%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs